Friday, March 19, 2010 | Follow Us:
Rosa Parks Transit Center - Marvin Shaouni
Rosa Parks Transit Center - Marvin Shaouni

Job News

Generic over-the-counter diabetes treatment to be manufactured by Caraco

Related Tags

Caraco Pharmaceutical continues on its forward roll with another FDA approval. This one is for the manufacture of lipizide/metformin hydrochloride tablets, a generic version of Bristol-Myers Squibb’s Metaglip.

Excerpt:

Sales of Metaglip and other generic versions accounted for $25 million in sales for the 12 months ending in September, Caraco said in a news release this week.

Read the entire article here.